- China
- /
- Healthcare Services
- /
- SZSE:300962
Earnings Troubles May Signal Larger Issues for Zhongjin Irradiation (SZSE:300962) Shareholders
Investors were disappointed by Zhongjin Irradiation Incorporated Company's (SZSE:300962 ) latest earnings release. Our analysis has found some reasons to be concerned, beyond the weak headline numbers.
Check out our latest analysis for Zhongjin Irradiation
The Impact Of Unusual Items On Profit
For anyone who wants to understand Zhongjin Irradiation's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥8.8m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. If Zhongjin Irradiation doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Zhongjin Irradiation.
Our Take On Zhongjin Irradiation's Profit Performance
Arguably, Zhongjin Irradiation's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Zhongjin Irradiation's true underlying earnings power is actually less than its statutory profit. Sadly, its EPS was down over the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. In terms of investment risks, we've identified 1 warning sign with Zhongjin Irradiation, and understanding it should be part of your investment process.
This note has only looked at a single factor that sheds light on the nature of Zhongjin Irradiation's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Valuation is complex, but we're here to simplify it.
Discover if Zhongjin Irradiation might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:300962
Flawless balance sheet with questionable track record.